Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$161.97 USD

161.97
575,208

+1.87 (1.17%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $161.95 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 6% (16 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

COO Stock Up 0.4% Following the Launch of New Inserter for Paragard IUD

Cooper Companies' latest launch is likely to simplify the insertion process of Paragard IUD, thus making it a more accessible contraceptive choice.

DaVita and Potlatch have been highlighted as Zacks Bull and Bear of the Day

DaVita and Potlatch are part of the Zacks Bull and Bear of the Day article.

Shaun Pruitt headshot

Bull of the Day: DaVita (DVA)

Seeing as DaVita's (DVA) growth is also crucial to societal health, its valuation is very intriguing at the moment as the leading provider of kidney care services in the United States.

Centene's Unit Secures New Four-Year Medicaid Contract in Iowa

CNC's unit, Iowa Total Care, wins a new contract to provide Medicaid managed care services, enhancing its presence in Iowa and bringing improved health outcomes in the state.

DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Shaun Pruitt headshot

Top Medical Stocks to Hedge Against the September Effect

Often sought out for defensive protection amid heightened market volatility, medical stocks may be of interest to investors in September which has historically been the most challenging month for stocks.

DaVita Rallies 44% Year to Date: What's Driving the Stock?

DVA's shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.

DaVita HealthCare (DVA) is a Great Momentum Stock: Should You Buy?

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Catalent's Stock Gains on Q4 Earnings Beat, Gross Margin Up

CTLT's solid segmental results led to an encouraging fiscal fourth-quarter performance, driving up share prices in after-hours trading.

Best Value Stocks to Buy for August 30th

RCMT, AIZ and DVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 30, 2024.

COO Stock Gains on Q3 Earnings & Revenue Beat, Margins Up

Cooper Companies' solid segmental results led to an encouraging fiscal third-quarter performance, driving up share prices in after-hours trading.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Zacks Analyst Blog Highlights DaVita and Illumina

DaVita and Illumina are included in this Analyst Blog.

Zacks Investment Ideas feature highlights: DaVita, Starwood Property and Philip Morris

DaVita, Starwood Property and Philip Morris have been highlighted in this Investment Ideas article.

Ethan Feller headshot

3 Defensive Stocks Outperforming in a Choppy Market (PM, DVA, STWD)

Philip Morris International, Starwood Property Trust and DaVita all show relative strength and top Zacks Ranks

PDCO Stock Falls on Q1 Earnings & Sales Miss, Gross Margin Up Y/Y

Patterson Companies' first-quarter fiscal 2025 results reflect the negative impact of a cyberattack on its vendor, Change Healthcare.

Indrajit Bandyopadhyay headshot

Aveanna Stock Rallies 110% in 3 Months: Is It Still Worth Buying?

AVAH stock has the potential to continue its uptrend on the back of a better payer rate environment and its focus on high-paying customers.

Nalak Das headshot

2 Must-Buy Medical Stocks With Strong Momentum

Two medical stocks with strong momentum and a favorable Zacks Rank are: DVA, ILMN.

Reasons to Retain Stryker Stock in Your Portfolio for Now

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

Reasons to Retain Fresenius Medical Stock in Your Portfolio Now

FMS continues to gain traction through its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.

Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

MCK Stock's Uptrend Likely to Continue After Core Ventures Acquisition

McKesson's agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Best Momentum Stock to Buy for August 27th

DVA, MRX and AIZ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 27, 2024.

Is DaVita (DVA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.